Back to search
C9ORF72 Amyotrophic Lateral Sclerosis (ALS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which C9ORF72 Amyotrophic Lateral Sclerosis (ALS) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which C9ORF72 Amyotrophic Lateral Sclerosis (ALS) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Pre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investiga…
Individuals with Amyotrophic Lateral Sclerosis (ALS) carrying the C9orf72 HRE mutation (C9Pos) often exhibit different phenotypic traits compared to other patie…
This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron…
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEF…
Background: \- Some people have a mutation in the C9ORF72 gene that causes amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). The mutation c…
Background: Amyotrophic lateral sclerosis (ALS) is a disorder that damages nerve cells in the brain and spinal cord. It can cause muscle weakness, paralysis, a…